Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chyongchiou J Lin

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of the National Medical Association|May 20, 2006
Parental perspectives on influenza vaccination of children with chronic medical conditionsChyongchiou J Lin, Richard K Zimmerman, Mary Patricia Nowalk, et al.
Journal of Occupational and Environmental Medicine|August 30, 2012
The comparative value of various employer-sponsored influenza vaccination clinicsRichard K Zimmerman, Ann E Wiringa, Mary Patricia Nowalk, et al.
American Journal of Preventive Medicine|November 30, 2024
Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older AdultsKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of the American Geriatrics Society|February 23, 2020
Cost-Effectiveness of Pneumococcal Vaccination Policies and Uptake Programs in US Older PopulationsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
American Journal of Preventive Medicine|February 1, 2020
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. PopulationsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
Vaccine|June 25, 2021
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysisKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of Community Health|August 12, 2019
Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged < 65 YearsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
The American Journal of Managed Care|November 5, 2005
Tailored interventions to introduce influenza vaccination among 6- to 23-month-old children at inner-city health centersMary Patricia Nowalk, Chyongchiou J Lin, Richard Kent Zimmerman, et al.
Human Vaccines & Immunotherapeutics|January 12, 2019
An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysisAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|April 7, 2010
Establish the habit: influenza vaccination for health care personnelMary Patricia Nowalk, Chyongchiou J Lin, Richard K Zimmerman, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of the National Medical Association|May 20, 2006
Parental perspectives on influenza vaccination of children with chronic medical conditionsChyongchiou J Lin, Richard K Zimmerman, Mary Patricia Nowalk, et al.
Journal of Occupational and Environmental Medicine|August 30, 2012
The comparative value of various employer-sponsored influenza vaccination clinicsRichard K Zimmerman, Ann E Wiringa, Mary Patricia Nowalk, et al.
American Journal of Preventive Medicine|November 30, 2024
Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older AdultsKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of the American Geriatrics Society|February 23, 2020
Cost-Effectiveness of Pneumococcal Vaccination Policies and Uptake Programs in US Older PopulationsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
American Journal of Preventive Medicine|February 1, 2020
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. PopulationsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
Vaccine|June 25, 2021
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysisKenneth J Smith, Angela R Wateska, Mary Patricia Nowalk, et al.
Journal of Community Health|August 12, 2019
Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged < 65 YearsAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
The American Journal of Managed Care|November 5, 2005
Tailored interventions to introduce influenza vaccination among 6- to 23-month-old children at inner-city health centersMary Patricia Nowalk, Chyongchiou J Lin, Richard Kent Zimmerman, et al.
Human Vaccines & Immunotherapeutics|January 12, 2019
An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysisAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|April 7, 2010
Establish the habit: influenza vaccination for health care personnelMary Patricia Nowalk, Chyongchiou J Lin, Richard K Zimmerman, et al.
Pageof 8